Secondary
Matinas BioPharma Holdings, Inc.
We are a clinical-stage biopharmaceutical company currently focused on enabling the delivery of life-changing medicines using our unique and proprietary, lipid nano-crystal (LNC) delivery technology platform
Symbol
MTNB
Last Closing Price
$0.57
Anticipated Date
TBD
Underwriters
ThinkEquity A Division of Fordham Financial Management, Inc.
To view the prospectus for Matinas BioPharma Holdings, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277